Cancer and non-cancer risks in normal and cancer-prone Trp53 heterozygous mice exposed to high-dose radiation

Radiation Research

Volumn 173, Issue 1, 2010, Pages 40-48

  Carlisle, S M ^a   Burchart, P A ^a   Mitchel, R E J ^a  

^a ATOMIC ENERGY OF CANADA LIMITED   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT 60;

ANIMAL EXPERIMENT; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GAMMA RADIATION; GENE; GENE FUNCTION; GENETIC DISORDER; GENOTYPE; HETEROZYGOSITY; LIFESPAN; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIOSENSITIVITY; TRP53 GENE;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEMANGIOSARCOMA; HETEROZYGOTE; LONGEVITY; LYMPHOMA; MALE; MICE; NEOPLASMS, RADIATION-INDUCED; RADIATION DOSAGE; RADIATION TOLERANCE; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; MUS;

EID: 73349107772     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1875.1     Document Type: Article

References (40)

1. ICRP, 1990 Recommendations of the International Commission for Radiological Protection. Publication 60, Annals of the ICRP, Pergamon Press, Oxford, 1991.
2. E. I. Azzam, S. M. de Toledo, G. P. Raaphorst and R. E. J. Mitchel, Radiation-induced radioresistance in a normal human skin fibroblast cell line. In Low Dose Irradiation and Biological Defense Mechanisms (T. Sugahara, L. A. Sagan and T. Aoyama, Eds. ), pp. 291-294. Elsevier Science, Amsterdam, 1992.
3. E. I. Azzam, S. M. de Toledo, G. P. Raaphorst and R. E. J. Mitchel, Réponse adaptative au rayonnement ionisant des fibroblastes de peau humaine. augmentation de la vitesse de réparation de l'ADN et variation de l'expression des gènes. J. Chim. Phys. 91, 931-936 (1994).
4. E. I. Azzam, G. P. Raaphorst and R. E. J. Mitchel, Radiation-induced adaptive response for protection against micronucleus formation and neoplastic transformation in C3H 10T 1/2 mouse embryo cells. Radiat. Res. 138 (Suppl. ), S28-S31 (1994).
5. E. J. Broome, D. L. Brown and R. E. J. Mitchel, Adaptation of human fibroblasts to radiation alters biases in DNA repair at the chromosome level. Int. J. Radiat. Biol. 75, 681-690 (1999).
6. 3H b particles in normal human fibroblasts. Radiat. Res. 158, 181-186 (2002).
7. O. Rigaud, D. Papadopoulo and E. Moustacchi, Decreased deletion mutation in radioadapted human lymphoblasts. Radiat. Res. 133, 94-101 (1993).
8. G. Olivieri, J. Bodycote and S. Wolff, Adaptive response of human lymphocytes to low concentration of radioactive thymidine. Science 223, 594-597 (1984).
9. K. Ishii, Y. Hosoi, S, Yamada, T. Ono and K. Sakamoto, Decreased incidence of thymic lymphoma in AKR mice as a result of chronic, fractionated low-dose total-body X irradiation. Radiat. Res. 146, 582-585 (1996).
10. R. E. J. Mitchel, J. S. Jackson, R. A. McCann and D. R. Boreham, The adaptive response modifies latency for radiation-induced myeloid leukemia in CBA/H mice. Radiat. Res. 152, 273-279 (1999).
11. R. E. J. Mitchel, E. I. Azzam and S. M. de Toledo, Adaption to ionizing radiation in mammalian cells, In Stress-Inducible Processes in Higher Eukaryotes (T. Koval, Ed. ), pp. 221-243. Plenum Press, New York, 1997.
12. E. I. Azzam, S. M. de Toledo, G. P. Raaphorst and R. E. J. Mitchel, Low-dose ionizing radiation decreases the frequency of neoplastic transformation to a level below the spontaneous rate in C3H 10T1/2 cells. Radiat. Res. 146, 369-373 (1996).
13. R. E. J. Mitchel, J-A. Dolling, J. Misonoh and D. R. Boreham, Influence of prior exposure to low-dose adapting radiation on radiation-induced teratogenic effects in fetal mice with varying Trp53 function. Radiat. Res. 158, 458-463 (2002).
14. H. Schöllnberger, R. E. J. Mitchel, E. I. Azzam, D. J. Crawford-Brown and W. Hofmann, Explanation of protective effects of low doses of c-radiation with a mechanistic radiobiological model. Int. J. Radiat. Biol. 78, 1159-1173 (2002).
15. J. L. Redpath and R. J. Antoniono, Induction of an adaptive response against spontaneous neoplastic transformation in vitro by low-dose gamma radiation. Radiat. Res. 149, 517-520 (1998).
16. J. L. Redpath, D. Liang, T. H. Taylor, C. Christie and E. Elmore, The shape of the dose-response curve for radiation-induced neoplastic transformation in vitro: evidence for an adaptive response against neoplastic transformation at low doses of low-LET radiation. Radiat. Res. 156, 700-707 (2001).
17. J. L. Redpath, Q. Lu, X. Lao, S. Molloi and E. Elmore, Low doses of diagnostic energy X-rays protect against neoplastic transformation in vitro. Int. J. Radiat. Biol. 79, 235-240 (2003).
18. S. P. Cregan, D. L. Brown and R. E. J. Mitchel, Apoptosis and the adaptive response in human lymphocytes. Int. J. Radiat. Biol. 75, 1087-1094 (1999).
19. R. E. J. Mitchel, J. S. Jackson, D. P. Morrison and S. M. Carlisle, Low doses of radiation increase the latency of spontaneous lymphomas and spinal osteosarcomas in cancer-prone, radiation-sensitive Trp53 heterozygous mice. Radiat. Res. 159, 320-327 (2003).
20. R. E. J. Mitchel, Low doses of radiation reduce risk in vivo. Dose Response 5, 1-10 (2007).
21. R. E. J. Mitchel, Low doses of radiation are protective in vitro and in vivo: Evolutionary origins. Dose Response 4, 75-90 (2006).
22. OECD, Scientific Issues and Emerging Challenges for Radiological Protection. Report of the Expert Group on the Implications of Radiological Protection Science. OECD Nuclear Energy Agency report No. 6167, OECD Publishing, Paris, 2007.
23. NRPB, Genetic Heterogeneity in the Population and its Implications for Radiation Risk. Documents of the NRPB, Vol. 10, No. 3, National Radiological Protection Board, Chilton, 1999.
24. ICRP, Genetic Susceptibility to Cancer. Recommendations of the International Commission on Radiological Protection. Publication 79, Annals of the ICRP, Vol.28, nos. 1/2, Elsevier, Amsterdam, 1998.
25. J. M. Lee, J. L. Abrahamson, R. Kandel, L. A. Donehower and A. Bernstein, Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice. Oncogene 9, 3731-3736 (1994).
26. Y. Saintigny, D. Rouillard, B. Chaput, T. Soussi and B. S. Lopez, Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint. Oncogene 18, 3553-3563 (1999).
27. P. J. Coates, S. A. Lorimore, K. J. Lindsay and E. G. Wright, Tissue-specific p53 responses to ionizing radiation and their genetic modification: the key to tissue-specific tumour susceptibility? J. Pathol. 201, 377-388 (2003).
28. M. Harvey, M. J. McArthur, C. A. Montgomery, Jr., J. S. Butel, A. Bradley and L. A. Donehower, Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat. Genet. 5, 225-229 (1993).
29. C. J. Kemp, T. Wheldon and A. Balmain, P53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nat. Genet. 8, 66-69 (1994).
30. z/2 hemizygous knockout mouse: Overview of available data. Toxicol. Pathol. 29 (Suppl. ), 30-50 (2001).
31. V. Gupta and S. M. Singh, Gender dimorphism in the myeloid differentiation of bone marrow precursor cells in a murine host bearing a T cell lymphoma. J. Reprod. Immunol. 74, 90-102 (2007).
32. R. E. J. Mitchel, J. S. Jackson and S. M. Carlisle, Upper dose thresholds for radiation-induced adaptive response against cancer in high-dose-exposed, cancer-prone, radiation-sensitive Trp53 heterozygous mice. Radiat. Res. 162, 20-30 (2004).
33. R. E. J. Mitchel, P. Burchart and H. Wyatt, Fractionated, low-dose-rate ionizing radiation exposure and spontaneous chronic ulcerative dermatitis in normal and Trp53 heterozygous C57BL/6 mice. Radiat. Res. 168, 716-724 (2007).
34. R. E. J. Mitchel, P. Burchart and H. Wyatt, A lower dose threshold for the in vivo protective adaptive response to radiation. Tumorigenesis in chronically exposed normal and Trp53 heterozygous C57BL/6 mice. Radiat. Res. 170, 765-775 (2008).
35. C. Barlow, M. A. Eckhaus, A. A. Schaffer and A. Wynshaw-Boris, Atm haploinsufficiency results in increased sensitivity to sublethal doses of ionizing radiation in mice. Nat. Genet. 21, 359-360 (1999).
36. T. Jacks, L. Remington, B. O. Williams, E. M. Schmitt, S. Halachmi, R. T. Bronson and R. A. Weinberg, Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1-7 (1994).
37. K. L. Burr, A. G. Smith and Y. E. Dubrova, P53 deficiency does not affect mutation rate in the mouse germline. Oncogene 24, 4315-4318 (2005).
38. C. J. Kemp, L. A. Donehower, A. Bradley and A. Balmain, Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 74, 813-822 (1993).
39. L. Liang, C. Shao, L. Deng, M. S. Mendonca, P. J. Stambrook and J. A. Tischfield, Radiation-induced genetic instability in vivo depends on p53 status. Mutat. Res. 502, 69-80 (2002).
40. K. Sankaranarayanan and R. Chakraborty, Cancer predisposition, radiosensitivity and the risk of radiation-induced cancers. I. Background. Radiat. Res. 143, 121-143 (1995).